2021-09-30
|
R-HSA-9754706
|
Atorvastatin ADME
|
BibTex
|
2021-09-06
|
R-HSA-9753281
|
Paracetamol ADME
|
BibTex
|
2021-07-27
|
R-HSA-9748787
|
Azathioprine ADME
|
BibTex
|
2021-07-27
|
R-HSA-9748784
|
Drug ADME
|
BibTex
|
2020-07-13
|
R-HSA-9694516
|
SARS-CoV-2 Infection
|
BibTex
|
2020-03-23
|
R-HSA-9679191
|
Potential therapeutics for SARS
|
BibTex
|
2020-02-05
|
R-HSA-9658195
|
Leishmania infection
|
BibTex
|
2020-01-09
|
R-HSA-9673324
|
WNT5:FZD7-mediated leishmania damping
|
BibTex
|
2020-01-07
|
R-HSA-9664424
|
Cell recruitment (pro-inflammatory response)
|
BibTex
|
2020-01-07
|
R-HSA-9660826
|
Purinergic signaling in leishmaniasis infection
|
BibTex
|
2020-01-07
|
R-HSA-9664420
|
Killing mechanisms
|
BibTex
|
2020-01-07
|
R-HSA-9664407
|
Parasite infection
|
BibTex
|
2020-01-07
|
R-HSA-9664417
|
Leishmania phagocytosis
|
BibTex
|
2020-01-07
|
R-HSA-9664422
|
FCGR3A-mediated phagocytosis
|
BibTex
|
2020-01-07
|
R-HSA-9664433
|
Leishmania parasite growth and survival
|
BibTex
|
2020-01-07
|
R-HSA-9662851
|
Anti-inflammatory response favouring Leishmania parasite infection
|
BibTex
|
2020-01-07
|
R-HSA-9660821
|
ADORA2B mediated anti-inflammatory cytokines production
|
BibTex
|
2020-01-07
|
R-HSA-9664323
|
FCGR3A-mediated IL10 synthesis
|
BibTex
|
2020-01-07
|
R-HSA-9662834
|
CD163 mediating an anti-inflammatory response
|
BibTex
|
2020-01-07
|
R-HSA-9664535
|
LTC4-CYSLTR mediated IL4 production
|
BibTex
|
2018-02-20
|
R-HSA-9037628
|
Rhesus blood group biosynthesis
|
BibTex
|
2018-02-20
|
R-HSA-9037629
|
Lewis blood group biosynthesis
|
BibTex
|
2017-12-28
|
R-HSA-9033807
|
ABO blood group biosynthesis
|
BibTex
|
2017-12-27
|
R-HSA-9033658
|
Blood group systems biosynthesis
|
BibTex
|
2017-11-03
|
R-HSA-9027604
|
Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives
|
BibTex
|
2017-10-30
|
R-HSA-9027307
|
Biosynthesis of maresin-like SPMs
|
BibTex
|
2017-10-23
|
R-HSA-9026766
|
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR)
|
BibTex
|
2017-10-23
|
R-HSA-9026762
|
Biosynthesis of maresin conjugates in tissue regeneration (MCTR)
|
BibTex
|
2017-10-19
|
R-HSA-9026395
|
Biosynthesis of DHA-derived sulfido conjugates
|
BibTex
|
2017-10-19
|
R-HSA-9026403
|
Biosynthesis of DPAn-3-derived 13-series resolvins
|
BibTex
|
2017-10-19
|
R-HSA-9026290
|
Biosynthesis of DPAn-3-derived maresins
|
BibTex
|
2017-10-19
|
R-HSA-9026286
|
Biosynthesis of DPAn-3-derived protectins and resolvins
|
BibTex
|
2017-10-12
|
R-HSA-9025094
|
Biosynthesis of DPAn-3 SPMs
|
BibTex
|
2017-10-12
|
R-HSA-9025106
|
Biosynthesis of DPAn-6 SPMs
|
BibTex
|
2017-09-28
|
R-HSA-9023661
|
Biosynthesis of E-series 18(R)-resolvins
|
BibTex
|
2017-09-05
|
R-HSA-9020265
|
Biosynthesis of aspirin-triggered D-series resolvins
|
BibTex
|
2017-09-05
|
R-HSA-9018896
|
Biosynthesis of E-series 18(S)-resolvins
|
BibTex
|
2017-09-04
|
R-HSA-9018678
|
Biosynthesis of specialized proresolving mediators (SPMs)
|
BibTex
|
2017-09-04
|
R-HSA-9018679
|
Biosynthesis of EPA-derived SPMs
|
BibTex
|
2017-09-04
|
R-HSA-9018677
|
Biosynthesis of DHA-derived SPMs
|
BibTex
|
2017-09-04
|
R-HSA-9018676
|
Biosynthesis of D-series resolvins
|
BibTex
|
2017-09-04
|
R-HSA-9018682
|
Biosynthesis of maresins
|
BibTex
|
2017-09-04
|
R-HSA-9018681
|
Biosynthesis of protectins
|
BibTex
|
2017-09-04
|
R-HSA-9018683
|
Biosynthesis of DPA-derived SPMs
|
BibTex
|
2017-02-10
|
R-HSA-8964540
|
Alanine metabolism
|
BibTex
|
2017-02-10
|
R-HSA-8964539
|
Glutamate and glutamine metabolism
|
BibTex
|
2017-02-10
|
R-HSA-8963693
|
Aspartate and asparagine metabolism
|
BibTex
|
2017-02-10
|
R-HSA-8963691
|
Phenylalanine and tyrosine metabolism
|
BibTex
|
2017-02-10
|
R-HSA-8963684
|
Tyrosine catabolism
|
BibTex
|
2016-10-11
|
R-HSA-8942233
|
Intestinal infectious diseases
|
BibTex
|
2016-08-30
|
R-HSA-8937144
|
Aryl hydrocarbon receptor signalling
|
BibTex
|
2016-08-15
|
R-HSA-8963743
|
Digestion and absorption
|
BibTex
|
2016-08-15
|
R-HSA-8935690
|
Digestion
|
BibTex
|
2016-06-27
|
R-HSA-8877627
|
Vitamin E
|
BibTex
|
2016-04-01
|
R-HSA-8866427
|
VLDLR internalisation and degradation
|
BibTex
|
2016-04-01
|
R-HSA-8866423
|
VLDL assembly
|
BibTex
|
2016-03-31
|
R-HSA-8866376
|
Reelin signalling pathway
|
BibTex
|
2016-02-11
|
R-HSA-8964572
|
Lipid particle organization
|
BibTex
|
2016-02-10
|
R-HSA-8964038
|
LDL clearance
|
BibTex
|
2016-02-10
|
R-HSA-8963889
|
Assembly of active LPL and LIPC lipase complexes
|
BibTex
|
2016-01-27
|
R-HSA-8964046
|
VLDL clearance
|
BibTex
|
2016-01-27
|
R-HSA-8964043
|
Plasma lipoprotein clearance
|
BibTex
|
2016-01-22
|
R-HSA-8853383
|
Lysosomal oligosaccharide catabolism
|
BibTex
|
2016-01-18
|
R-HSA-8852405
|
Signaling by MST1
|
BibTex
|
2015-12-14
|
R-HSA-8849175
|
Threonine catabolism
|
BibTex
|
2015-09-22
|
R-HSA-6799198
|
Complex I biogenesis
|
BibTex
|
2015-09-17
|
R-HSA-6798163
|
Choline catabolism
|
BibTex
|
2015-07-15
|
R-HSA-6787639
|
GDP-fucose biosynthesis
|
BibTex
|
2015-06-18
|
R-HSA-6783984
|
Glycine degradation
|
BibTex
|
2015-04-28
|
R-HSA-5690338
|
Defective ABCC6 causes PXE
|
BibTex
|
2015-04-20
|
R-HSA-5688890
|
Defective CSF2RA causes SMDP4
|
BibTex
|
2015-04-20
|
R-HSA-5688849
|
Defective CSF2RB causes SMDP5
|
BibTex
|
2015-04-16
|
R-HSA-5688399
|
Defective ABCA3 causes SMDP3
|
BibTex
|
2015-04-16
|
R-HSA-5688354
|
Defective pro-SFTPC causes SMDP2 and RDS
|
BibTex
|
2015-04-13
|
R-HSA-5688031
|
Defective pro-SFTPB causes SMDP1 and RDS
|
BibTex
|
2015-04-10
|
R-HSA-5687868
|
Defective SFTPA2 causes IPF
|
BibTex
|
2015-04-08
|
R-HSA-5687613
|
Diseases associated with surfactant metabolism
|
BibTex
|
2015-04-08
|
R-HSA-5687583
|
Defective SLC34A2 causes PALM
|
BibTex
|
2015-03-18
|
R-HSA-5684045
|
Defective ABCD1 causes ALD
|
BibTex
|
2015-03-17
|
R-HSA-5683826
|
Surfactant metabolism
|
BibTex
|
2015-03-16
|
R-HSA-5683678
|
Defective ABCA3 causes SMDP3
|
BibTex
|
2015-03-13
|
R-HSA-5683371
|
Defective ABCB6 causes MCOPCB7
|
BibTex
|
2015-03-13
|
R-HSA-5683329
|
Defective ABCD4 causes MAHCJ
|
BibTex
|
2015-03-12
|
R-HSA-5683177
|
Defective ABCC8 can cause hypo- and hyper-glycemias
|
BibTex
|
2015-03-06
|
R-HSA-5682294
|
Defective ABCA12 causes ARCI4B
|
BibTex
|
2015-03-05
|
R-HSA-5682113
|
Defective ABCA1 causes TGD
|
BibTex
|
2015-03-02
|
R-HSA-5679096
|
Defective ABCG5 causes sitosterolemia
|
BibTex
|
2015-03-02
|
R-HSA-5679090
|
Defective ABCG8 causes GBD4 and sitosterolemia
|
BibTex
|
2015-02-27
|
R-HSA-5679001
|
Defective ABCC2 causes DJS
|
BibTex
|
2015-02-26
|
R-HSA-5678895
|
Defective CFTR causes cystic fibrosis
|
BibTex
|
2015-02-26
|
R-HSA-5678771
|
Defective ABCB4 causes PFIC3, ICP3 and GBD1
|
BibTex
|
2015-02-24
|
R-HSA-5678520
|
Defective ABCB11 causes PFIC2 and BRIC2
|
BibTex
|
2015-02-24
|
R-HSA-5678420
|
Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome
|
BibTex
|
2015-01-30
|
R-HSA-5669034
|
TNFs bind their physiological receptors
|
BibTex
|
2014-10-31
|
R-HSA-5633231
|
Defective ALG14 causes ALG14-CMS
|
BibTex
|
2014-08-22
|
R-HSA-5619115
|
Disorders of transmembrane transporters
|
BibTex
|
2014-08-22
|
R-HSA-5619102
|
SLC transporter disorders
|
BibTex
|
2014-08-22
|
R-HSA-5619114
|
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)
|
BibTex
|
2014-08-22
|
R-HSA-5619113
|
Defective SLC3A1 causes cystinuria (CSNU)
|
BibTex
|
2014-08-22
|
R-HSA-5656364
|
Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)
|
BibTex
|
2014-08-22
|
R-HSA-5663020
|
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
|
BibTex
|
2014-08-22
|
R-HSA-5619107
|
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
|
BibTex
|
2014-08-22
|
R-HSA-5619104
|
Defective SLC12A1 causes Bartter syndrome 1 (BS1)
|
BibTex
|
2014-08-22
|
R-HSA-5619110
|
Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)
|
BibTex
|
2014-08-22
|
R-HSA-5619111
|
Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)
|
BibTex
|
2014-08-22
|
R-HSA-5619108
|
Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)
|
BibTex
|
2014-08-22
|
R-HSA-5619109
|
Defective SLC6A2 causes orthostatic intolerance (OI)
|
BibTex
|
2014-08-22
|
R-HSA-5660862
|
Defective SLC7A7 causes lysinuric protein intolerance (LPI)
|
BibTex
|
2014-08-22
|
R-HSA-5660724
|
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
|
BibTex
|
2014-08-22
|
R-HSA-5619083
|
Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)
|
BibTex
|
2014-08-22
|
R-HSA-5619081
|
Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
|
BibTex
|
2014-08-22
|
R-HSA-5619087
|
Defective SLC12A3 causes Gitelman syndrome (GS)
|
BibTex
|
2014-08-22
|
R-HSA-5660686
|
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)
|
BibTex
|
2014-08-22
|
R-HSA-5619085
|
Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)
|
BibTex
|
2014-08-22
|
R-HSA-5619072
|
Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)
|
BibTex
|
2014-08-22
|
R-HSA-5619073
|
Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)
|
BibTex
|
2014-08-22
|
R-HSA-5619078
|
Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)
|
BibTex
|
2014-08-22
|
R-HSA-5619079
|
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria
|
BibTex
|
2014-08-22
|
R-HSA-5619076
|
Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25)
|
BibTex
|
2014-08-22
|
R-HSA-5619077
|
Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)
|
BibTex
|
2014-08-22
|
R-HSA-5619098
|
Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS)
|
BibTex
|
2014-08-22
|
R-HSA-5619099
|
Defective AVP does not bind AVPR1A,B and causes neurohypophyseal diabetes insipidus (NDI)
|
BibTex
|
2014-08-22
|
R-HSA-5619096
|
Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)
|
BibTex
|
2014-08-22
|
R-HSA-5619097
|
Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)
|
BibTex
|
2014-08-22
|
R-HSA-5619101
|
Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)
|
BibTex
|
2014-08-22
|
R-HSA-5619088
|
Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)
|
BibTex
|
2014-08-22
|
R-HSA-5619089
|
Defective SLC6A5 causes hyperekplexia 3 (HKPX3)
|
BibTex
|
2014-08-22
|
R-HSA-5619094
|
Variant SLC6A14 may confer susceptibility towards obesity
|
BibTex
|
2014-08-22
|
R-HSA-5619095
|
Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)
|
BibTex
|
2014-08-22
|
R-HSA-5619092
|
Defective SLC9A6 causes X-linked, syndromic mental retardation,, Christianson type (MRXSCH)
|
BibTex
|
2014-08-22
|
R-HSA-5619050
|
Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)
|
BibTex
|
2014-08-22
|
R-HSA-5619048
|
Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)
|
BibTex
|
2014-08-22
|
R-HSA-5619049
|
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)
|
BibTex
|
2014-08-22
|
R-HSA-5619054
|
Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)
|
BibTex
|
2014-08-22
|
R-HSA-5619055
|
Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)
|
BibTex
|
2014-08-22
|
R-HSA-5619052
|
Defective SLC9A9 causes autism 16 (AUTS16)
|
BibTex
|
2014-08-22
|
R-HSA-5619053
|
Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)
|
BibTex
|
2014-08-22
|
R-HSA-5619042
|
Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)
|
BibTex
|
2014-08-22
|
R-HSA-5658208
|
Defective SLC5A2 causes renal glucosuria (GLYS1)
|
BibTex
|
2014-08-22
|
R-HSA-5619043
|
Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)
|
BibTex
|
2014-08-22
|
R-HSA-5619040
|
Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)
|
BibTex
|
2014-08-22
|
R-HSA-9036092
|
Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)
|
BibTex
|
2014-08-22
|
R-HSA-5619041
|
Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG)
|
BibTex
|
2014-08-22
|
R-HSA-5619046
|
Defective SLC26A4 causes Pendred syndrome (PDS)
|
BibTex
|
2014-08-22
|
R-HSA-5619047
|
Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)
|
BibTex
|
2014-08-22
|
R-HSA-5619044
|
Defective SLC6A19 causes Hartnup disorder (HND)
|
BibTex
|
2014-08-22
|
R-HSA-5658471
|
Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)
|
BibTex
|
2014-08-22
|
R-HSA-5619045
|
Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)
|
BibTex
|
2014-08-22
|
R-HSA-5619066
|
Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)
|
BibTex
|
2014-08-22
|
R-HSA-5619067
|
Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)
|
BibTex
|
2014-08-22
|
R-HSA-5619084
|
ABC transporter disorders
|
BibTex
|
2014-08-22
|
R-HSA-5659735
|
Defective SLC6A19 causes Hartnup disorder (HND)
|
BibTex
|
2014-08-22
|
R-HSA-5660883
|
Defective SLC7A9 causes cystinuria (CSNU)
|
BibTex
|
2014-08-22
|
R-HSA-5659729
|
Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria
|
BibTex
|
2014-08-22
|
R-HSA-5619037
|
Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
|
BibTex
|
2014-08-22
|
R-HSA-5619036
|
Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6)
|
BibTex
|
2014-08-22
|
R-HSA-5619039
|
Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)
|
BibTex
|
2014-08-22
|
R-HSA-5619035
|
Defective SLC17A5 causes Salla disease (SD) and ISSD
|
BibTex
|
2014-08-22
|
R-HSA-5619061
|
Defective SLC33A1 causes spastic paraplegia 42 (SPG42)
|
BibTex
|
2014-08-22
|
R-HSA-5619060
|
Defective CP causes aceruloplasminemia (ACERULOP)
|
BibTex
|
2014-08-22
|
R-HSA-5655799
|
Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)
|
BibTex
|
2014-08-22
|
R-HSA-5619063
|
Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)
|
BibTex
|
2014-08-22
|
R-HSA-5619062
|
Defective SLC1A3 causes episodic ataxia 6 (EA6)
|
BibTex
|
2014-08-22
|
R-HSA-5619056
|
Defective HK1 causes hexokinase deficiency (HK deficiency)
|
BibTex
|
2014-08-22
|
R-HSA-5619058
|
Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)
|
BibTex
|
2014-08-22
|
R-HSA-5619068
|
Defective SLC2A10 causes arterial tortuosity syndrome (ATS)
|
BibTex
|
2014-08-22
|
R-HSA-5619071
|
Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)
|
BibTex
|
2014-08-22
|
R-HSA-5619070
|
Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)
|
BibTex
|
2014-07-18
|
R-HSA-5609975
|
Diseases associated with glycosylation precursor biosynthesis
|
BibTex
|
2014-07-18
|
R-HSA-5609978
|
Defective GALT can cause GALCT
|
BibTex
|
2014-07-18
|
R-HSA-5609976
|
Defective GALK1 causes GALCT2
|
BibTex
|
2014-07-18
|
R-HSA-5609977
|
Defective GALE causes EDG
|
BibTex
|
2014-07-18
|
R-HSA-5609974
|
Defective PGM1 causes PGM1-CDG
|
BibTex
|
2014-06-06
|
R-HSA-5579031
|
Defective ACTH causes obesity and POMCD
|
BibTex
|
2014-06-06
|
R-HSA-5579029
|
Metabolic disorders of biological oxidation enzymes
|
BibTex
|
2014-06-06
|
R-HSA-5579002
|
Defective UGT1A1 causes hyperbilirubinemia
|
BibTex
|
2014-06-06
|
R-HSA-5579000
|
Defective CYP1B1 causes Glaucoma
|
BibTex
|
2014-06-06
|
R-HSA-5579006
|
Defective GSS causes GSS deficiency
|
BibTex
|
2014-06-06
|
R-HSA-5579007
|
Defective ACY1 causes encephalopathy
|
BibTex
|
2014-06-06
|
R-HSA-5579004
|
Defective CYP26C1 causes FFDD4
|
BibTex
|
2014-06-06
|
R-HSA-5579005
|
Defective CYP4F22 causes ARCI5
|
BibTex
|
2014-06-06
|
R-HSA-5578995
|
Defective TPMT causes TPMT deficiency
|
BibTex
|
2014-06-06
|
R-HSA-5578998
|
Defective OPLAH causes OPLAHD
|
BibTex
|
2014-06-06
|
R-HSA-5578999
|
Defective GCLC causes HAGGSD
|
BibTex
|
2014-06-06
|
R-HSA-5578996
|
Defective CYP27A1 causes CTX
|
BibTex
|
2014-06-06
|
R-HSA-5578997
|
Defective AHCY causes HMAHCHD
|
BibTex
|
2014-06-06
|
R-HSA-5579019
|
Defective FMO3 causes TMAU
|
BibTex
|
2014-06-06
|
R-HSA-5579016
|
Defective UGT1A4 causes hyperbilirubinemia
|
BibTex
|
2014-06-06
|
R-HSA-5579017
|
Defective CYP11B1 causes AH4
|
BibTex
|
2014-06-06
|
R-HSA-5579022
|
Defective GGT1 causes GLUTH
|
BibTex
|
2014-06-06
|
R-HSA-5579020
|
Defective SLC35D1 causes SCHBCKD
|
BibTex
|
2014-06-06
|
R-HSA-5579028
|
Defective CYP17A1 causes AH5
|
BibTex
|
2014-06-06
|
R-HSA-5579030
|
Defective CYP19A1 causes AEXS
|
BibTex
|
2014-06-06
|
R-HSA-5579024
|
Defective MAT1A causes MATD
|
BibTex
|
2014-06-06
|
R-HSA-5579027
|
Defective CYP27B1 causes VDDR1B
|
BibTex
|
2014-06-06
|
R-HSA-5579026
|
Defective CYP11A1 causes AICSR
|
BibTex
|
2014-06-06
|
R-HSA-9035968
|
Defective GGT1 in aflatoxin detoxification causes GLUTH
|
BibTex
|
2014-06-06
|
R-HSA-5579032
|
Defective TBXAS1 causes GHDD
|
BibTex
|
2014-06-06
|
R-HSA-5579013
|
Defective CYP7B1 causes SPG5A and CBAS3
|
BibTex
|
2014-06-06
|
R-HSA-5579012
|
Defective MAOA causes BRUNS
|
BibTex
|
2014-06-06
|
R-HSA-5579015
|
Defective CYP26B1 causes RHFCA
|
BibTex
|
2014-06-06
|
R-HSA-5579014
|
Defective CYP27B1 causes VDDR1A
|
BibTex
|
2014-06-06
|
R-HSA-5579009
|
Defective CYP11B2 causes CMO-1 deficiency
|
BibTex
|
2014-06-06
|
R-HSA-5579011
|
Defective CYP2U1 causes SPG56
|
BibTex
|
2014-06-06
|
R-HSA-5579010
|
Defective CYP24A1 causes HCAI
|
BibTex
|
2014-06-06
|
R-HSA-5579021
|
Defective CYP21A2 causes AH3
|
BibTex
|
2014-06-02
|
R-HSA-5578768
|
Physiological factors
|
BibTex
|
2014-06-02
|
R-HSA-5578775
|
Ion homeostasis
|
BibTex
|
2014-05-27
|
R-HSA-5576891
|
Cardiac conduction
|
BibTex
|
2014-05-27
|
R-HSA-5576892
|
Phase 0 - rapid depolarisation
|
BibTex
|
2014-05-27
|
R-HSA-5576894
|
Phase 1 - inactivation of fast Na+ channels
|
BibTex
|
2014-05-27
|
R-HSA-5576893
|
Phase 2 - plateau phase
|
BibTex
|
2014-05-27
|
R-HSA-5576890
|
Phase 3 - rapid repolarisation
|
BibTex
|
2014-05-27
|
R-HSA-5576886
|
Phase 4 - resting membrane potential
|
BibTex
|
2014-05-09
|
R-HSA-5423646
|
Aflatoxin activation and detoxification
|
BibTex
|
2014-04-16
|
R-HSA-5362517
|
Signaling by Retinoic Acid
|
BibTex
|
2014-04-16
|
R-HSA-5365859
|
RA biosynthesis pathway
|
BibTex
|
2014-01-06
|
R-HSA-5223345
|
Miscellaneous transport and binding events
|
BibTex
|
2013-11-25
|
R-HSA-5173105
|
O-linked glycosylation
|
BibTex
|
2013-11-25
|
R-HSA-5173214
|
O-glycosylation of TSR domain-containing proteins
|
BibTex
|
2013-11-07
|
R-HSA-5083635
|
Defective B3GALTL causes PpS
|
BibTex
|
2013-11-07
|
R-HSA-5083632
|
Defective C1GALT1C1 causes TNPS
|
BibTex
|
2013-11-07
|
R-HSA-5083633
|
Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
|
BibTex
|
2013-11-07
|
R-HSA-5083636
|
Defective GALNT12 causes CRCS1
|
BibTex
|
2013-11-07
|
R-HSA-5083627
|
Defective LARGE causes MDDGA6 and MDDGB6
|
BibTex
|
2013-11-07
|
R-HSA-5083625
|
Defective GALNT3 causes HFTC
|
BibTex
|
2013-11-07
|
R-HSA-5083630
|
Defective LFNG causes SCDO3
|
BibTex
|
2013-11-07
|
R-HSA-5083628
|
Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3
|
BibTex
|
2013-11-07
|
R-HSA-5083629
|
Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
|
BibTex
|
2013-10-29
|
R-HSA-4793952
|
Defective MGAT2 causes CDG-2a
|
BibTex
|
2013-10-25
|
R-HSA-4755583
|
Defective DOLK causes DOLK-CDG
|
BibTex
|
2013-10-25
|
R-HSA-4755579
|
Defective SRD5A3 causes SRD5A3-CDG, KHRZ
|
BibTex
|
2013-10-25
|
R-HSA-4755609
|
Defective DHDDS causes RP59
|
BibTex
|
2013-10-23
|
R-HSA-4724325
|
Defective ALG8 causes CDG-1h
|
BibTex
|
2013-10-23
|
R-HSA-4724289
|
Defective ALG6 causes CDG-1c
|
BibTex
|
2013-10-21
|
R-HSA-4720475
|
Defective ALG3 causes CDG-1d
|
BibTex
|
2013-10-21
|
R-HSA-4720489
|
Defective ALG12 causes CDG-1g
|
BibTex
|
2013-10-21
|
R-HSA-4720454
|
Defective ALG9 causes CDG-1l
|
BibTex
|
2013-10-18
|
R-HSA-4719377
|
Defective DPM2 causes DPM2-CDG
|
BibTex
|
2013-10-18
|
R-HSA-4719360
|
Defective DPM3 causes DPM3-CDG
|
BibTex
|
2013-10-17
|
R-HSA-4717374
|
Defective DPM1 causes DPM1-CDG
|
BibTex
|
2013-10-15
|
R-HSA-4687000
|
Defective MPDU1 causes CDG-1f
|
BibTex
|
2013-09-23
|
R-HSA-4570571
|
Defective RFT1 causes CDG-1n
|
BibTex
|
2013-09-13
|
R-HSA-4551295
|
Defective ALG11 causes CDG-1p
|
BibTex
|
2013-09-12
|
R-HSA-4549356
|
Defective DPAGT1 causes CDG-1j, CMSTA2
|
BibTex
|
2013-09-12
|
R-HSA-4549380
|
Defective ALG1 causes CDG-1k
|
BibTex
|
2013-09-12
|
R-HSA-4549349
|
Defective ALG2 causes CDG-1i
|
BibTex
|
2013-09-03
|
R-HSA-4420332
|
Defective B3GALT6 causes EDSP2 and SEMDJL1
|
BibTex
|
2013-08-21
|
R-HSA-4341670
|
Defective NEU1 causes sialidosis
|
BibTex
|
2013-08-01
|
R-HSA-4085011
|
Defective GNE causes sialuria, NK and IBM2
|
BibTex
|
2013-08-01
|
R-HSA-4085023
|
Defective GFPT1 causes CMSTA1
|
BibTex
|
2013-08-01
|
R-HSA-4085001
|
Sialic acid metabolism
|
BibTex
|
2013-07-29
|
R-HSA-4793950
|
Defective MAN1B1 causes MRT15
|
BibTex
|
2013-07-29
|
R-HSA-4793954
|
Defective MOGS causes CDG-2b
|
BibTex
|
2013-07-29
|
R-HSA-4793953
|
Defective B4GALT1 causes CDG-2d
|
BibTex
|
2013-07-29
|
R-HSA-4043911
|
Defective PMM2 causes PMM2-CDG
|
BibTex
|
2013-07-29
|
R-HSA-4043916
|
Defective MPI causes MPI-CDG
|
BibTex
|
2013-07-17
|
R-HSA-3906995
|
Diseases associated with O-glycosylation of proteins
|
BibTex
|
2013-06-28
|
R-HSA-3781865
|
Diseases of glycosylation
|
BibTex
|
2013-06-28
|
R-HSA-3781860
|
Diseases associated with N-glycosylation of proteins
|
BibTex
|
2013-05-31
|
R-HSA-3656234
|
Defective HEXA causes GM2G1
|
BibTex
|
2013-05-31
|
R-HSA-3656237
|
Defective EXT2 causes exostoses 2
|
BibTex
|
2013-05-31
|
R-HSA-3656225
|
Defective CHST6 causes MCDC1
|
BibTex
|
2013-05-31
|
R-HSA-3656248
|
Defective HEXB causes GM2G2
|
BibTex
|
2013-05-31
|
R-HSA-3656253
|
Defective EXT1 causes exostoses 1, TRPS2 and CHDS
|
BibTex
|
2013-05-31
|
R-HSA-3656243
|
Defective ST3GAL3 causes MCT12 and EIEE15
|
BibTex
|
2013-05-31
|
R-HSA-3656244
|
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
|
BibTex
|
2013-05-21
|
R-HSA-3560782
|
Diseases associated with glycosaminoglycan metabolism
|
BibTex
|
2013-05-21
|
R-HSA-3595177
|
Defective CHSY1 causes TPBS
|
BibTex
|
2013-05-21
|
R-HSA-3560783
|
Defective B4GALT7 causes EDS, progeroid type
|
BibTex
|
2013-05-21
|
R-HSA-3560801
|
Defective B3GAT3 causes JDSSDHD
|
BibTex
|
2013-05-21
|
R-HSA-3595172
|
Defective CHST3 causes SEDCJD
|
BibTex
|
2013-05-21
|
R-HSA-3595174
|
Defective CHST14 causes EDS, musculocontractural type
|
BibTex
|
2013-05-21
|
R-HSA-3560792
|
Defective SLC26A2 causes chondrodysplasias
|
BibTex
|
2013-05-21
|
R-HSA-3560796
|
Defective PAPSS2 causes SEMD-PA
|
BibTex
|
2013-05-13
|
R-HSA-9759785
|
Diseases of propionyl-CoA catabolism
|
BibTex
|
2013-05-13
|
R-HSA-3359478
|
Defective MUT causes MMAM
|
BibTex
|
2013-05-13
|
R-HSA-3359485
|
Defective CD320 causes MMATC
|
BibTex
|
2013-05-13
|
R-HSA-3359469
|
Defective MTR causes HMAG
|
BibTex
|
2013-05-13
|
R-HSA-3359454
|
Defective TCN2 causes TCN2 deficiency
|
BibTex
|
2013-05-13
|
R-HSA-3359471
|
Defective MMAB causes MMA, cblB type
|
BibTex
|
2013-05-13
|
R-HSA-3359467
|
Defective MTRR causes HMAE
|
BibTex
|
2013-05-13
|
R-HSA-3359462
|
Defective AMN causes MGA1
|
BibTex
|
2013-05-13
|
R-HSA-3359463
|
Defective CUBN causes MGA1
|
BibTex
|
2013-05-13
|
R-HSA-3359473
|
Defective MMADHC causes MMAHCD
|
BibTex
|
2013-05-13
|
R-HSA-3359457
|
Defective CBLIF causes IFD
|
BibTex
|
2013-05-13
|
R-HSA-3359474
|
Defective MMACHC causes MAHCC
|
BibTex
|
2013-05-13
|
R-HSA-3359475
|
Defective MMAA causes MMA, cblA type
|
BibTex
|
2013-05-13
|
R-HSA-3371598
|
Defective BTD causes biotidinase deficiency
|
BibTex
|
2013-05-13
|
R-HSA-3371599
|
Defective HLCS causes multiple carboxylase deficiency
|
BibTex
|
2013-05-09
|
R-HSA-3323169
|
Defects in biotin (Btn) metabolism
|
BibTex
|
2013-04-18
|
R-HSA-3296482
|
Defects in vitamin and cofactor metabolism
|
BibTex
|
2013-04-18
|
R-HSA-3296469
|
Defects in cobalamin (B12) metabolism
|
BibTex
|
2013-04-17
|
R-HSA-3295583
|
TRP channels
|
BibTex
|
2012-11-27
|
R-HSA-2672351
|
Stimuli-sensing channels
|
BibTex
|
2012-10-11
|
R-HSA-2514859
|
Inactivation, recovery and regulation of the phototransduction cascade
|
BibTex
|
2012-10-11
|
R-HSA-2514856
|
The phototransduction cascade
|
BibTex
|
2012-10-01
|
R-HSA-2485179
|
Activation of the phototransduction cascade
|
BibTex
|
2012-09-25
|
R-HSA-2474795
|
Diseases associated with visual transduction
|
BibTex
|
2012-09-12
|
R-HSA-2466712
|
Biosynthesis of A2E, implicated in retinal degradation
|
BibTex
|
2012-08-17
|
R-HSA-2453864
|
Retinoid cycle disease events
|
BibTex
|
2012-08-17
|
R-HSA-6809583
|
Retinoid metabolism disease events
|
BibTex
|
2012-08-17
|
R-HSA-2453902
|
The canonical retinoid cycle in rods (twilight vision)
|
BibTex
|
2012-04-26
|
R-HSA-2206281
|
Mucopolysaccharidoses
|
BibTex
|
2012-04-26
|
R-HSA-2206302
|
MPS I - Hurler syndrome
|
BibTex
|
2012-04-26
|
R-HSA-2206305
|
MPS IIID - Sanfilippo syndrome D
|
BibTex
|
2012-04-26
|
R-HSA-2206307
|
MPS IIIA - Sanfilippo syndrome A
|
BibTex
|
2012-04-26
|
R-HSA-2206291
|
MPS IIIC - Sanfilippo syndrome C
|
BibTex
|
2012-04-26
|
R-HSA-2206290
|
MPS IV - Morquio syndrome A
|
BibTex
|
2012-04-26
|
R-HSA-2206308
|
MPS IV - Morquio syndrome B
|
BibTex
|
2012-04-26
|
R-HSA-2206292
|
MPS VII - Sly syndrome
|
BibTex
|
2012-04-26
|
R-HSA-2206296
|
MPS II - Hunter syndrome
|
BibTex
|
2012-04-26
|
R-HSA-2206280
|
MPS IX - Natowicz syndrome
|
BibTex
|
2012-04-26
|
R-HSA-2206282
|
MPS IIIB - Sanfilippo syndrome B
|
BibTex
|
2012-04-26
|
R-HSA-2206285
|
MPS VI - Maroteaux-Lamy syndrome
|
BibTex
|
2012-04-09
|
R-HSA-2187338
|
Visual phototransduction
|
BibTex
|
2012-04-09
|
R-HSA-2187335
|
The retinoid cycle in cones (daylight vision)
|
BibTex
|
2012-04-04
|
R-HSA-881907
|
Gastrin-CREB signalling pathway via PKC and MAPK
|
BibTex
|
2012-04-04
|
R-HSA-2179392
|
EGFR Transactivation by Gastrin
|
BibTex
|
2012-03-05
|
R-HSA-2160916
|
Hyaluronan uptake and degradation
|
BibTex
|
2012-02-24
|
R-HSA-2142845
|
Hyaluronan metabolism
|
BibTex
|
2012-02-24
|
R-HSA-2142850
|
Hyaluronan biosynthesis and export
|
BibTex
|
2011-12-14
|
R-HSA-2024101
|
CS/DS degradation
|
BibTex
|
2011-12-14
|
R-HSA-2024096
|
HS-GAG degradation
|
BibTex
|
2011-12-01
|
R-HSA-2022870
|
Chondroitin sulfate biosynthesis
|
BibTex
|
2011-12-01
|
R-HSA-2022923
|
Dermatan sulfate biosynthesis
|
BibTex
|
2011-12-01
|
R-HSA-2022928
|
HS-GAG biosynthesis
|
BibTex
|
2011-12-01
|
R-HSA-2022857
|
Keratan sulfate degradation
|
BibTex
|
2011-12-01
|
R-HSA-2022854
|
Keratan sulfate biosynthesis
|
BibTex
|
2011-11-04
|
R-HSA-1971475
|
A tetrasaccharide linker sequence is required for GAG synthesis
|
BibTex
|
2011-10-21
|
R-HSA-1793185
|
Chondroitin sulfate/dermatan sulfate metabolism
|
BibTex
|
2011-10-14
|
R-HSA-1663150
|
The activation of arylsulfatases
|
BibTex
|
2011-10-14
|
R-HSA-1660662
|
Glycosphingolipid metabolism
|
BibTex
|
2011-10-07
|
R-HSA-1638091
|
Heparan sulfate/heparin (HS-GAG) metabolism
|
BibTex
|
2011-10-05
|
R-HSA-1630316
|
Glycosaminoglycan metabolism
|
BibTex
|
2011-10-05
|
R-HSA-1638074
|
Keratan sulfate/keratin metabolism
|
BibTex
|
2011-08-17
|
R-HSA-1474151
|
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
|
BibTex
|
2011-07-04
|
R-HSA-1369007
|
Mitochondrial ABC transporters
|
BibTex
|
2011-07-04
|
R-HSA-1369062
|
ABC transporters in lipid homeostasis
|
BibTex
|
2010-11-02
|
R-HSA-983712
|
Ion channel transport
|
BibTex
|
2010-10-15
|
R-HSA-977068
|
Termination of O-glycan biosynthesis
|
BibTex
|
2010-10-01
|
R-HSA-975634
|
Retinoid metabolism and transport
|
BibTex
|
2010-08-24
|
R-HSA-936837
|
Ion transport by P-type ATPases
|
BibTex
|
2010-07-19
|
R-HSA-913709
|
O-linked glycosylation of mucins
|
BibTex
|
2010-06-18
|
R-HSA-879518
|
Transport of organic anions
|
BibTex
|
2010-05-26
|
R-HSA-804914
|
Transport of fatty acids
|
BibTex
|
2010-05-12
|
R-HSA-727802
|
Transport of nucleotide sugars
|
BibTex
|
2010-03-25
|
R-HSA-561048
|
Organic anion transport
|
BibTex
|
2010-03-17
|
R-HSA-549132
|
Organic cation/anion/zwitterion transport
|
BibTex
|
2010-03-17
|
R-HSA-549127
|
Organic cation transport
|
BibTex
|
2010-02-05
|
R-HSA-500792
|
GPCR ligand binding
|
BibTex
|
2009-10-23
|
R-HSA-444411
|
Rhesus glycoproteins mediate ammonium transport.
|
BibTex
|
2009-09-29
|
R-HSA-442660
|
Na+/Cl- dependent neurotransmitter transporters
|
BibTex
|
2009-09-25
|
R-HSA-442380
|
Zinc influx into cells by the SLC39 gene family
|
BibTex
|
2009-09-09
|
R-HSA-435354
|
Zinc transporters
|
BibTex
|
2009-09-09
|
R-HSA-435368
|
Zinc efflux and compartmentalization by the SLC30 family
|
BibTex
|
2009-08-25
|
R-HSA-433692
|
Proton-coupled monocarboxylate transport
|
BibTex
|
2009-08-21
|
R-HSA-433137
|
Sodium-coupled sulphate, di- and tri-carboxylate transporters
|
BibTex
|
2009-07-17
|
R-HSA-429593
|
Inositol transporters
|
BibTex
|
2009-07-06
|
R-HSA-428559
|
Proton-coupled neutral amino acid transporters
|
BibTex
|
2009-07-06
|
R-HSA-428643
|
Organic anion transporters
|
BibTex
|
2009-06-30
|
R-HSA-427975
|
Proton/oligopeptide cotransporters
|
BibTex
|
2009-06-23
|
R-HSA-427601
|
Multifunctional anion exchangers
|
BibTex
|
2009-06-23
|
R-HSA-427652
|
Sodium-coupled phosphate cotransporters
|
BibTex
|
2009-06-23
|
R-HSA-427589
|
Type II Na+/Pi cotransporters
|
BibTex
|
2009-06-12
|
R-HSA-426117
|
Cation-coupled Chloride cotransporters
|
BibTex
|
2009-06-11
|
R-HSA-425986
|
Sodium/Proton exchangers
|
BibTex
|
2009-06-05
|
R-HSA-425561
|
Sodium/Calcium exchangers
|
BibTex
|
2009-06-04
|
R-HSA-425407
|
SLC-mediated transmembrane transport
|
BibTex
|
2009-06-04
|
R-HSA-425397
|
Transport of vitamins, nucleosides, and related molecules
|
BibTex
|
2009-06-04
|
R-HSA-425366
|
Transport of bile salts and organic acids, metal ions and amine compounds
|
BibTex
|
2009-06-04
|
R-HSA-425410
|
Metal ion SLC transporters
|
BibTex
|
2009-06-04
|
R-HSA-425393
|
Transport of inorganic cations/anions and amino acids/oligopeptides
|
BibTex
|
2009-06-04
|
R-HSA-425381
|
Bicarbonate transporters
|
BibTex
|
2009-05-12
|
R-HSA-420499
|
Class C/3 (Metabotropic glutamate/pheromone receptors)
|
BibTex
|
2009-05-11
|
R-HSA-420092
|
Glucagon-type ligand receptors
|
BibTex
|
2009-05-07
|
R-HSA-419812
|
Calcitonin-like ligand receptors
|
BibTex
|
2009-05-07
|
R-HSA-419771
|
Opsins
|
BibTex
|
2009-04-30
|
R-HSA-419408
|
Lysosphingolipid and LPA receptors
|
BibTex
|
2009-04-14
|
R-HSA-418038
|
Nucleotide-like (purinergic) receptors
|
BibTex
|
2009-04-14
|
R-HSA-417957
|
P2Y receptors
|
BibTex
|
2009-04-14
|
R-HSA-417973
|
Adenosine P1 receptors
|
BibTex
|
2009-04-02
|
R-HSA-391908
|
Prostanoid ligand receptors
|
BibTex
|
2009-03-26
|
R-HSA-391906
|
Leukotriene receptors
|
BibTex
|
2009-02-27
|
R-HSA-392170
|
ADP signalling through P2Y purinoceptor 12
|
BibTex
|
2009-02-25
|
R-HSA-391903
|
Eicosanoid ligand-binding receptors
|
BibTex
|
2009-02-23
|
R-HSA-375281
|
Hormone ligand-binding receptors
|
BibTex
|
2009-02-12
|
R-HSA-390666
|
Serotonin receptors
|
BibTex
|
2009-02-11
|
R-HSA-390650
|
Histamine receptors
|
BibTex
|
2009-02-10
|
R-HSA-390651
|
Dopamine receptors
|
BibTex
|
2009-02-10
|
R-HSA-390696
|
Adrenoceptors
|
BibTex
|
2009-02-10
|
R-HSA-390648
|
Muscarinic acetylcholine receptors
|
BibTex
|
2009-01-07
|
R-HSA-389397
|
Orexin and neuropeptides FF and QRFP bind to their respective receptors
|
BibTex
|
2008-12-12
|
R-HSA-388479
|
Vasopressin-like receptors
|
BibTex
|
2008-11-24
|
R-HSA-380095
|
Tachykinin receptors bind tachykinins
|
BibTex
|
2008-11-24
|
R-HSA-186797
|
Signaling by PDGF
|
BibTex
|
2008-11-24
|
R-HSA-186763
|
Downstream signal transduction
|
BibTex
|
2008-11-07
|
R-HSA-380108
|
Chemokine receptors bind chemokines
|
BibTex
|
2008-10-01
|
R-HSA-209952
|
Peptide hormone biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-209822
|
Glycoprotein hormones
|
BibTex
|
2008-10-01
|
R-HSA-196108
|
Pregnenolone biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-193993
|
Mineralocorticoid biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-193144
|
Estrogen biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-193048
|
Androgen biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-194002
|
Glucocorticoid biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-209776
|
Metabolism of amine-derived hormones
|
BibTex
|
2008-10-01
|
R-HSA-209931
|
Serotonin and melatonin biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-209968
|
Thyroxine biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-196791
|
Vitamin D (calciferol) metabolism
|
BibTex
|
2008-10-01
|
R-HSA-209905
|
Catecholamine biosynthesis
|
BibTex
|
2008-10-01
|
R-HSA-350864
|
Regulation of thyroid hormone activity
|
BibTex
|
2008-08-21
|
R-HSA-375280
|
Amine ligand-binding receptors
|
BibTex
|
2008-08-21
|
R-HSA-375276
|
Peptide ligand-binding receptors
|
BibTex
|
2008-07-14
|
R-HSA-373080
|
Class B/2 (Secretin family receptors)
|
BibTex
|
2008-07-03
|
R-HSA-373076
|
Class A/1 (Rhodopsin-like receptors)
|
BibTex
|
2008-07-02
|
R-HSA-372790
|
Signaling by GPCR
|
BibTex
|
2008-05-19
|
R-HSA-211859
|
Biological oxidations
|
BibTex
|
2008-05-19
|
R-HSA-211945
|
Phase I - Functionalization of compounds
|
BibTex
|
2008-05-19
|
R-HSA-211897
|
Cytochrome P450 - arranged by substrate type
|
BibTex
|
2008-05-19
|
R-HSA-211916
|
Vitamins
|
BibTex
|
2008-05-19
|
R-HSA-211981
|
Xenobiotics
|
BibTex
|
2008-05-19
|
R-HSA-211999
|
CYP2E1 reactions
|
BibTex
|
2008-05-19
|
R-HSA-211957
|
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2
|
BibTex
|
2008-05-19
|
R-HSA-211935
|
Fatty acids
|
BibTex
|
2008-05-19
|
R-HSA-211976
|
Endogenous sterols
|
BibTex
|
2008-05-19
|
R-HSA-211994
|
Sterols are 12-hydroxylated by CYP8B1
|
BibTex
|
2008-05-19
|
R-HSA-211979
|
Eicosanoids
|
BibTex
|
2008-05-19
|
R-HSA-211958
|
Miscellaneous substrates
|
BibTex
|
2008-05-19
|
R-HSA-71384
|
Ethanol oxidation
|
BibTex
|
2008-05-19
|
R-HSA-140180
|
COX reactions
|
BibTex
|
2008-05-19
|
R-HSA-217271
|
FMO oxidises nucleophiles
|
BibTex
|
2008-05-19
|
R-HSA-141334
|
PAOs oxidise polyamines to amines
|
BibTex
|
2008-05-19
|
R-HSA-141333
|
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB
|
BibTex
|
2008-05-19
|
R-HSA-140179
|
Amine Oxidase reactions
|
BibTex
|
2008-02-28
|
R-HSA-177929
|
Signaling by EGFR
|
BibTex
|
2008-02-13
|
R-HSA-212718
|
EGFR interacts with phospholipase C-gamma
|
BibTex
|
2007-08-21
|
R-HSA-201556
|
Signaling by ALK
|
BibTex
|
2007-05-02
|
R-HSA-197264
|
Nicotinamide salvaging
|
BibTex
|
2007-04-24
|
R-HSA-196854
|
Metabolism of vitamins and cofactors
|
BibTex
|
2007-04-24
|
R-HSA-196849
|
Metabolism of water-soluble vitamins and cofactors
|
BibTex
|
2007-04-24
|
R-HSA-196780
|
Biotin transport and metabolism
|
BibTex
|
2007-04-24
|
R-HSA-196783
|
Coenzyme A biosynthesis
|
BibTex
|
2007-04-24
|
R-HSA-196807
|
Nicotinate metabolism
|
BibTex
|
2007-04-24
|
R-HSA-196819
|
Vitamin B1 (thiamin) metabolism
|
BibTex
|
2007-04-24
|
R-HSA-9758881
|
Uptake of dietary cobalamins into enterocytes
|
BibTex
|
2007-04-24
|
R-HSA-9759218
|
Cobalamin (Cbl) metabolism
|
BibTex
|
2007-04-24
|
R-HSA-9758890
|
Transport of RCbl within the body
|
BibTex
|
2007-04-24
|
R-HSA-196741
|
Cobalamin (Cbl, vitamin B12) transport and metabolism
|
BibTex
|
2007-04-24
|
R-HSA-196836
|
Vitamin C (ascorbate) metabolism
|
BibTex
|
2007-04-21
|
R-HSA-196071
|
Metabolism of steroid hormones
|
BibTex
|
2007-02-03
|
R-HSA-556833
|
Metabolism of lipids
|
BibTex
|
2007-02-03
|
R-HSA-8978868
|
Fatty acid metabolism
|
BibTex
|
2007-02-03
|
R-HSA-8979227
|
Triglyceride metabolism
|
BibTex
|
2007-01-24
|
R-HSA-8957322
|
Metabolism of steroids
|
BibTex
|
2007-01-24
|
R-HSA-191273
|
Cholesterol biosynthesis
|
BibTex
|
2007-01-24
|
R-HSA-189451
|
Heme biosynthesis
|
BibTex
|
2007-01-19
|
R-HSA-194068
|
Bile acid and bile salt metabolism
|
BibTex
|
2007-01-19
|
R-HSA-192105
|
Synthesis of bile acids and bile salts
|
BibTex
|
2007-01-19
|
R-HSA-193368
|
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
|
BibTex
|
2006-02-17
|
R-HSA-174362
|
Transport and synthesis of PAPS
|
BibTex
|
2006-02-02
|
R-HSA-170834
|
Signaling by TGF-beta Receptor Complex
|
BibTex
|
2005-11-09
|
R-HSA-166187
|
Mitochondrial Uncoupling
|
BibTex
|
2005-06-29
|
R-HSA-163210
|
Formation of ATP by chemiosmotic coupling
|
BibTex
|
2005-06-16
|
R-DME-110523
|
TOR signaling pathway
|
BibTex
|
2005-06-14
|
R-DME-5252538
|
Drosophila signaling pathways
|
BibTex
|
2005-06-14
|
R-DME-110526
|
Insulin receptor mediated signaling
|
BibTex
|
2005-04-21
|
R-HSA-163200
|
Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
|
BibTex
|
2005-04-21
|
R-HSA-611105
|
Respiratory electron transport
|
BibTex
|
2005-03-10
|
R-HSA-156587
|
Amino Acid conjugation
|
BibTex
|
2005-03-10
|
R-HSA-159424
|
Conjugation of carboxylic acids
|
BibTex
|
2005-03-09
|
R-HSA-159418
|
Recycling of bile acids and salts
|
BibTex
|
2005-02-03
|
R-HSA-156581
|
Methylation
|
BibTex
|
2004-12-15
|
R-HSA-157118
|
Signaling by NOTCH
|
BibTex
|
2004-12-15
|
R-HSA-1980145
|
Signaling by NOTCH2
|
BibTex
|
2004-12-15
|
R-HSA-9012852
|
Signaling by NOTCH3
|
BibTex
|
2004-12-15
|
R-HSA-9013694
|
Signaling by NOTCH4
|
BibTex
|
2004-12-15
|
R-HSA-1912420
|
Pre-NOTCH Processing in Golgi
|
BibTex
|
2004-11-30
|
R-HSA-173599
|
Formation of the active cofactor, UDP-glucuronate
|
BibTex
|
2004-11-30
|
R-HSA-174403
|
Glutathione synthesis and recycling
|
BibTex
|
2004-11-30
|
R-HSA-177135
|
Conjugation of benzoate with glycine
|
BibTex
|
2004-11-30
|
R-HSA-177128
|
Conjugation of salicylate with glycine
|
BibTex
|
2004-11-30
|
R-HSA-177162
|
Conjugation of phenylacetate with glutamine
|
BibTex
|
2004-11-30
|
R-HSA-156582
|
Acetylation
|
BibTex
|
2004-11-30
|
R-HSA-156590
|
Glutathione conjugation
|
BibTex
|
2004-11-29
|
R-HSA-156580
|
Phase II - Conjugation of compounds
|
BibTex
|
2004-11-29
|
R-HSA-156588
|
Glucuronidation
|
BibTex
|
2004-11-29
|
R-HSA-156584
|
Cytosolic sulfonation of small molecules
|
BibTex
|
2004-03-31
|
R-HSA-111885
|
Opioid Signalling
|
BibTex
|
2004-03-31
|
R-HSA-202040
|
G-protein activation
|
BibTex
|
2004-03-31
|
R-HSA-180024
|
DARPP-32 events
|
BibTex
|
2004-03-31
|
R-HSA-112040
|
G-protein mediated events
|
BibTex
|
2004-03-31
|
R-HSA-112043
|
PLC beta mediated events
|
BibTex
|
2004-03-31
|
R-HSA-111996
|
Ca-dependent events
|
BibTex
|
2004-03-31
|
R-HSA-111995
|
phospho-PLA2 pathway
|
BibTex
|
2004-03-31
|
R-HSA-170660
|
Adenylate cyclase activating pathway
|
BibTex
|
2004-03-31
|
R-HSA-111957
|
Cam-PDE 1 activation
|
BibTex
|
2004-03-31
|
R-HSA-163615
|
PKA activation
|
BibTex
|
2004-03-31
|
R-HSA-111931
|
PKA-mediated phosphorylation of CREB
|
BibTex
|
2004-03-31
|
R-HSA-111932
|
CaMK IV-mediated phosphorylation of CREB
|
BibTex
|
2004-03-31
|
R-HSA-111933
|
Calmodulin induced events
|
BibTex
|
2004-03-31
|
R-HSA-111997
|
CaM pathway
|
BibTex
|
2004-03-31
|
R-HSA-170670
|
Adenylate cyclase inhibitory pathway
|
BibTex
|
2004-02-11
|
R-DME-110478
|
Insulin signaling pathway
|
BibTex
|
2003-07-17
|
R-HSA-74217
|
Purine salvage
|
BibTex
|
2003-07-17
|
R-HSA-74259
|
Purine catabolism
|
BibTex
|
2003-06-26
|
R-HSA-15869
|
Metabolism of nucleotides
|
BibTex
|
2003-06-26
|
R-HSA-8956321
|
Nucleotide salvage
|
BibTex
|
2003-06-26
|
R-HSA-8956320
|
Nucleotide biosynthesis
|
BibTex
|
2003-06-26
|
R-HSA-73817
|
Purine ribonucleoside monophosphate biosynthesis
|
BibTex
|
2003-06-26
|
R-HSA-8956319
|
Nucleotide catabolism
|
BibTex
|
2003-06-17
|
R-HSA-73621
|
Pyrimidine catabolism
|
BibTex
|
2003-06-17
|
R-HSA-73614
|
Pyrimidine salvage
|
BibTex
|